BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,755,967 | -4.0% | 46,528 | +15.9% | 0.03% | -3.6% |
| Q2 2023 | $1,829,416 | +11.9% | 40,154 | -0.4% | 0.03% | -3.4% |
| Q1 2023 | $1,635,258 | -19.4% | 40,317 | +1.3% | 0.03% | -29.3% |
| Q4 2022 | $2,029,574 | -5.4% | 39,819 | -0.1% | 0.04% | -16.3% |
| Q3 2022 | $2,146,000 | -14.9% | 39,849 | +1.5% | 0.05% | -19.7% |
| Q2 2022 | $2,521,000 | -6.2% | 39,256 | +13.2% | 0.06% | +7.0% |
| Q1 2022 | $2,688,000 | -9.3% | 34,669 | +0.3% | 0.06% | -8.1% |
| Q4 2021 | $2,965,000 | +6.0% | 34,550 | -0.7% | 0.06% | -6.1% |
| Q3 2021 | $2,797,000 | -0.7% | 34,777 | -0.6% | 0.07% | -1.5% |
| Q2 2021 | $2,816,000 | -4.6% | 34,983 | -0.1% | 0.07% | -13.0% |
| Q1 2021 | $2,953,000 | +6.7% | 35,016 | +1.5% | 0.08% | -2.5% |
| Q4 2020 | $2,768,000 | -0.9% | 34,508 | -0.7% | 0.08% | -11.2% |
| Q3 2020 | $2,794,000 | -2.5% | 34,744 | +4.3% | 0.09% | -10.1% |
| Q2 2020 | $2,866,000 | +7.3% | 33,297 | +1.2% | 0.10% | -10.0% |
| Q1 2020 | $2,672,000 | -1.9% | 32,916 | +1.1% | 0.11% | +19.6% |
| Q4 2019 | $2,723,000 | -6.6% | 32,565 | -2.3% | 0.09% | -15.6% |
| Q3 2019 | $2,916,000 | +15.4% | 33,343 | +8.1% | 0.11% | +6.9% |
| Q2 2019 | $2,526,000 | -18.1% | 30,844 | -18.7% | 0.10% | +100.0% |
| Q1 2019 | $3,085,000 | +28.3% | 37,952 | +3.8% | 0.05% | +18.6% |
| Q4 2018 | $2,405,000 | -18.3% | 36,549 | -4.3% | 0.04% | -4.4% |
| Q3 2018 | $2,943,000 | +4.0% | 38,188 | -0.4% | 0.04% | +4.7% |
| Q2 2018 | $2,830,000 | +18.7% | 38,338 | +4.5% | 0.04% | +22.9% |
| Q1 2018 | $2,385,000 | +2.1% | 36,673 | +1.4% | 0.04% | 0.0% |
| Q4 2017 | $2,337,000 | +0.6% | 36,169 | -2.4% | 0.04% | -2.8% |
| Q3 2017 | $2,324,000 | +0.1% | 37,051 | -3.4% | 0.04% | -5.3% |
| Q2 2017 | $2,321,000 | +10.9% | 38,351 | -5.0% | 0.04% | +8.6% |
| Q1 2017 | $2,093,000 | -42.4% | 40,361 | -50.8% | 0.04% | -50.0% |
| Q4 2016 | $3,636,000 | -17.0% | 82,006 | -10.9% | 0.07% | -26.3% |
| Q3 2016 | $4,381,000 | -9.8% | 92,044 | -14.3% | 0.10% | -35.8% |
| Q2 2016 | $4,856,000 | +9.6% | 107,404 | -0.4% | 0.15% | +8.0% |
| Q1 2016 | $4,429,000 | +3.3% | 107,826 | -4.1% | 0.14% | -5.5% |
| Q4 2015 | $4,289,000 | +18.5% | 112,434 | +2.1% | 0.14% | +16.9% |
| Q3 2015 | $3,618,000 | +26.5% | 110,158 | +169.3% | 0.12% | +36.3% |
| Q2 2015 | $2,859,000 | -2.9% | 40,898 | -4.9% | 0.09% | +1.1% |
| Q1 2015 | $2,944,000 | -13.2% | 42,985 | -7.1% | 0.09% | -13.5% |
| Q4 2014 | $3,390,000 | -6.0% | 46,256 | -8.0% | 0.10% | -6.3% |
| Q3 2014 | $3,608,000 | -7.2% | 50,282 | -6.6% | 0.11% | 0.0% |
| Q2 2014 | $3,890,000 | -7.5% | 53,816 | -5.8% | 0.11% | -10.5% |
| Q1 2014 | $4,204,000 | -0.7% | 57,146 | -6.2% | 0.12% | +1.6% |
| Q4 2013 | $4,235,000 | -2.3% | 60,898 | -7.7% | 0.12% | -1.6% |
| Q3 2013 | $4,334,000 | -9.3% | 65,987 | -4.3% | 0.12% | -8.1% |
| Q2 2013 | $4,777,000 | – | 68,963 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |